Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Cleveland › NPI 1194763045
Hospital

Lutheran Hospital

Lutheran Hospital was paid $41.49M by Medicaid between Jan 2018 and Dec 2024, across 331 billing codes. Its largest line is 96361, Intravenous infusion, hydration; each additional hour — 18% of everything it billed.

33Billing provider infoLUTHERAN HOSPITAL
CLEVELAND, OH 44113
33aNPI1194763045assigned 06/03/2006
28Total paid$41.49M
24GClaims1,006,218
24DCodes billed331
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Ohio

Rank by total paid#26 of 101
Median peer was paid$22.32M
This provider vs. median1.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official LARAWAY, DENNIS controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201891,094$3.10M
201994,268$3.47M
202073,164$4.22M
202197,607$5.19M
202296,681$4.46M
2023304,563$12.23M
2024incomplete248,841$8.83M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
96361 Intravenous infusion, hydration; each additional hour 18% 25,221 20,025 $7.49M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 14% 49,394 45,240 $5.74M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 13% 42,019 36,887 $5.50M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 12% 45,833 42,876 $5.05M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 3.8% 23,755 10,053 $1.58M
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 2.8% 9,870 8,509 $1.14M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 2.7% 14,700 11,643 $1.14M
70450 Computed tomography, head or brain; without contrast material 2.4% 3,707 3,154 $993K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2.3% 6,728 6,078 $958K
74177 Computed tomography, abdomen and pelvis; with contrast material 2.0% 3,388 2,793 $836K
27447 1.9% 278 208 $779K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.5% 3,642 3,239 $614K
319 more codes
G0378 Hospital observation service, per hour 1.4% 7,297 $573K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.3% 4,553 $524K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.2% 3,896 $486K
90853 Group psychotherapy (other than of a multiple-family group) 1.1% 4,653 $448K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 1.1% 2,332 $437K
C1776 Joint device (implantable) 1.0% 734 $430K
80053 Comprehensive metabolic panel <1% 55,736 $404K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 3,066 $378K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 1,563 $350K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 1,009 $276K
90870 <1% 1,034 $226K
64483 <1% 549 $204K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 17,342 $195K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 5,065 $186K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 873 $182K
90839 <1% 1,491 $168K
70498 <1% 570 $154K
99232 Hospital visit by a doctor, follow-up day <1% 7,889 $149K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 4,679 $133K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 1,402 $121K
73564 <1% 2,499 $110K
93975 <1% 1,031 $110K
97161 <1% 3,810 $101K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,301 $101K
76770 <1% 658 $92K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 4,257 $91K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 210 $89K
84439 <1% 3,816 $86K
97535 Self-care/home management training, each 15 minutes <1% 2,937 $81K
84484 <1% 24,896 $77K
71046 Radiologic examination, chest; 2 views <1% 13,657 $75K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 44,892 $72K
80048 Basic metabolic panel (calcium, ionized) <1% 9,389 $70K
77067 Screening mammography, bilateral, including computer-aided detection <1% 2,043 $68K
84443 Thyroid stimulating hormone (TSH) <1% 5,920 $67K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 1,043 $66K
87631 <1% 498 $64K
93971 <1% 1,013 $61K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 234 $59K
80061 Lipid panel <1% 4,844 $57K
93970 <1% 411 $55K
64447 <1% 406 $55K
83036 Hemoglobin; glycosylated (A1C) <1% 4,128 $53K
11045 <1% 262 $52K
76830 Ultrasound, transvaginal <1% 1,058 $51K
97165 <1% 1,239 $50K
36415 Collection of venous blood by venipuncture <1% 54,142 $49K
27130 <1% 22 $46K
81513 <1% 390 $45K
70491 <1% 133 $42K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 399 $42K
73130 <1% 1,899 $42K
73030 <1% 1,756 $41K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 259 $39K
97802 <1% 554 $38K
73502 <1% 1,240 $36K
97803 <1% 464 $34K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 33,588 $33K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 163 $33K
86850 <1% 1,613 $33K
85027 <1% 19,000 $32K
71250 <1% 385 $31K
96367 <1% 834 $29K
97116 <1% 1,439 $27K
72100 <1% 1,272 $27K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 1,217 $26K
12001 <1% 172 $26K
93799 <1% 4,484 $25K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 4,819 $24K
73630 <1% 1,601 $24K
71275 Computed tomographic angiography, chest, with contrast material <1% 78 $24K
73562 <1% 465 $23K
72125 Computed tomography, cervical spine; without contrast material <1% 1,763 $23K
10060 <1% 121 $19K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 23,181 $19K
86803 <1% 879 $19K
72131 <1% 380 $18K
80320 <1% 1,951 $18K
71045 Radiologic examination, chest; single view <1% 9,578 $18K
83735 <1% 17,651 $18K
70551 Magnetic resonance imaging, brain; without contrast material <1% 121 $18K
76536 <1% 198 $17K
86900 <1% 1,634 $17K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 4,888 $16K
82728 <1% 1,185 $15K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 887 $15K
77063 Screening digital breast tomosynthesis, bilateral <1% 333 $15K
73110 <1% 1,012 $15K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 15,456 $14K
82962 <1% 11,305 $13K
82607 <1% 1,007 $13K
81001 <1% 46,679 $13K
93017 <1% 231 $13K
97162 <1% 304 $13K
73610 <1% 1,264 $12K
99213 Doctor's office visit, returning patient (routine) <1% 676 $12K
90792 Psychiatric diagnostic evaluation with medical services <1% 76 $12K
73560 <1% 909 $12K
70486 <1% 515 $11K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 782 $11K
87086 Culture, bacterial; quantitative colony count, urine <1% 5,298 $11K
86780 <1% 2,781 $11K
83540 <1% 1,307 $10K
85610 <1% 5,317 $10K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 566 $10K
84702 <1% 1,618 $10K
76857 <1% 1,007 $9K
90715 <1% 735 $9K
99233 Hospital visit by a doctor, follow-up day (complex) <1% 335 $9K
99308 Subsequent nursing facility care, per day, straightforward <1% 1,168 $9K
82805 <1% 383 $9K
87340 <1% 662 $8K
86140 <1% 1,220 $8K
83550 <1% 1,280 $7K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 325 $7K
86901 <1% 1,633 $7K
74183 <1% 30 $7K
72050 <1% 159 $7K
82570 <1% 828 $7K
0001A <1% 169 $6K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 54 $6K
70496 <1% 597 $6K
85379 <1% 4,563 $6K
00104 <1% 1,012 $6K
84100 <1% 2,001 $6K
0002A <1% 150 $6K
96376 <1% 2,608 $6K
83970 <1% 315 $5K
73080 <1% 499 $5K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 4,687 $5K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 34 $5K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 3,239 $5K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 530 $5K
86706 <1% 385 $5K
80076 <1% 528 $5K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 14 $5K
76642 <1% 42 $4K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 5,100 $4K
96368 <1% 121 $4K
82077 <1% 4,723 $4K
83880 <1% 2,313 $4K
74018 <1% 252 $4K
96375 Therapeutic injection; each additional sequential IV push <1% 10,228 $4K
76942 <1% 184 $4K
80197 <1% 252 $4K
81025 <1% 20,767 $4K
82043 <1% 614 $4K
76801 <1% 453 $3K
80069 <1% 282 $3K
73700 <1% 25 $3K
99231 Subsequent hospital care, per day, straightforward or low complexity <1% 266 $3K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 27 $3K
82550 <1% 3,546 $3K
76882 <1% 30 $3K
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 856 $3K
87077 <1% 1,561 $3K
90791 Psychiatric diagnostic evaluation <1% 13 $3K
73590 <1% 431 $3K
99307 <1% 520 $3K
J3490 Unclassified drugs <1% 514 $3K
74022 <1% 339 $3K
82553 <1% 173 $2K
73140 <1% 323 $2K
J1756 Injection, iron sucrose, 1 mg <1% 79 $2K
73221 <1% 12 $2K
86703 <1% 2,221 $2K
83690 <1% 10,680 $2K
72110 <1% 59 $2K
99225 <1% 142 $2K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 709 $2K
82977 <1% 160 $2K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,369 $2K
73523 <1% 39 $2K
94660 <1% 20 $2K
86704 <1% 137 $2K
C9290 Injection, bupivacaine liposome, 1 mg <1% 28 $2K
72072 <1% 124 $2K
99222 Initial hospital care, per day, moderate complexity <1% 35 $2K
73090 <1% 291 $2K
71101 <1% 207 $2K
72040 <1% 41 $1K
85652 <1% 610 $1K
80365 <1% 149 $1K
J1815 Injection, insulin, per 5 units <1% 211 $1K
85730 <1% 1,810 $1K
84550 <1% 357 $1K
87522 Neg quan hep c or qual rna <1% 73 $1K
77080 <1% 26 $1K
82746 <1% 390 $1K
87481 <1% 288 $1K
87186 <1% 1,257 $1K
72128 <1% 21 $1K
76870 <1% 89 $1K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 12 $1K
84132 <1% 807 $1K
84156 <1% 339 $989.11
87430 <1% 2,540 $963.84
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 30,390 $952.49
84153 <1% 61 $939.90
82947 <1% 507 $924.01
Q3014 Telehealth originating site facility fee <1% 33 $879.37
11043 <1% 16 $873.79
82330 <1% 474 $754.87
A9270 Non-covered item or service <1% 2,762 $714.37
73070 <1% 12 $683.72
87070 <1% 571 $682.13
83605 <1% 1,902 $650.42
87205 <1% 728 $626.47
86431 <1% 54 $589.32
80164 <1% 235 $560.66
J2270 Injection, morphine sulfate, up to 10 mg <1% 2,279 $558.52
84165 <1% 88 $554.02
84703 <1% 1,343 $520.51
99214 Doctor's office visit, returning patient (more involved) <1% 13 $471.21
85018 <1% 484 $447.15
87040 <1% 782 $440.13
74019 <1% 61 $417.86
J0690 Injection, cefazolin sodium, 500 mg <1% 3,516 $379.80
84155 <1% 111 $376.73
J1644 Injection, heparin sodium, per 1000 units <1% 1,263 $374.08
90714 <1% 34 $340.09
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 7,538 $309.26
86038 <1% 16 $304.31
82533 <1% 20 $303.40
C9113 Injection, pantoprazole sodium, per vial <1% 363 $301.22
J2704 Injection, propofol, 10 mg <1% 3,086 $291.67
J1170 Injection, hydromorphone, up to 4 mg <1% 916 $283.52
87640 <1% 17 $277.52
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 26 $255.86
83615 <1% 62 $230.33
84481 <1% 44 $229.55
86160 <1% 19 $229.02
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 820 $218.66
86480 <1% 14 $188.22
99152 <1% 603 $183.34
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 412 $166.44
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 31 $165.54
87641 <1% 17 $163.82
82435 <1% 394 $161.85
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg <1% 55 $155.76
87808 <1% 234 $150.39
82375 <1% 565 $128.05
82042 <1% 14 $127.14
72170 <1% 196 $123.98
J1790 Injection, droperidol, up to 5 mg <1% 1,175 $117.77
82784 <1% 35 $99.79
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,887 $99.75
73660 <1% 16 $99.23
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 1,069 $99.14
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 9,520 $96.45
86308 <1% 26 $95.23
84295 <1% 391 $93.42
J2060 Injection, lorazepam, 2 mg <1% 835 $92.47
85045 <1% 51 $83.69
J0360 Injection, hydralazine hcl, up to 20 mg <1% 127 $81.02
Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml <1% 1,071 $77.86
J3475 Injection, magnesium sulfate, per 500 mg <1% 1,454 $77.25
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 182 $73.29
J1650 Injection, enoxaparin sodium, 10 mg <1% 54 $71.86
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 15 $69.90
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,415 $69.81
82010 <1% 245 $66.70
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 328 $66.58
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 1,009 $65.45
84145 <1% 37 $64.71
80143 <1% 55 $64.45
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 2,670 $63.46
83050 <1% 390 $61.30
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 33 $58.74
86592 <1% 45 $58.70
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 5,047 $53.48
94644 <1% 28 $52.48
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,918 $52.12
J1040 Injection, methylprednisolone acetate, 80 mg <1% 731 $46.42
86705 <1% 14 $45.49
83521 <1% 19 $43.95
94760 <1% 3,465 $39.40
J3370 Injection, vancomycin hcl, 500 mg <1% 331 $39.22
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,133 $36.95
J7030 Infusion, normal saline solution , 1000 cc <1% 195 $32.31
J1630 Injection, haloperidol, up to 5 mg <1% 220 $32.26
87899 <1% 14 $31.33
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,243 $30.90
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 591 $27.85
J3480 Injection, potassium chloride, per 2 meq <1% 552 $21.35
87088 <1% 59 $19.43
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 12 $18.26
J0780 Injection, prochlorperazine, up to 10 mg <1% 165 $17.94
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 805 $17.08
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose <1% 505 $12.36
J1010 Injection, methylprednisolone acetate, 1 mg <1% 88 $11.20
J7120 Ringers lactate infusion, up to 1000 cc <1% 463 $10.82
J2470 Injection, pantoprazole sodium, 40 mg <1% 38 $7.98
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg <1% 73 $5.29
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 16 $5.02
J2004 Injection, lidocaine hcl with epinephrine, 1 mg <1% 34 $4.80
J1940 Injection, furosemide, up to 20 mg <1% 35 $4.54
J1171 Injection, hydromorphone, 0.1 mg <1% 55 $3.31
91300 <1% 319 $3.08
J1030 Injection, methylprednisolone acetate, 40 mg <1% 36 $3.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 1,245 $2.67
J1596 Injection, glycopyrrolate, 0.1 mg <1% 409 $2.55
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 362 $1.55
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose 0% 226 $0.00
01402 0% 280 $0.00
76376 0% 66 $0.00
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm 0% 23 $0.00
01810 0% 14 $0.00
82272 0% 34 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 24 $0.00
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) 0% 12 $0.00
J2370 Injection, phenylephrine hcl, up to 1 ml 0% 69 $0.00
74174 0% 13 $0.00
J2785 Injection, regadenoson, 0.1 mg 0% 197 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 0% 182 $0.00
87081 0% 56 $0.00
01214 0% 22 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 31 $0.00
88304 0% 35 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLARAWAY, DENNIS (EXECUTIVE VP CHIEF FINANCE OFFICER)
Same official

Other billing entities under LARAWAY, DENNIS

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.